LSCDS #ScienceNews and #Innovation

Written By Kyla Germain

This week in #ScienceNews and #Innovation, the United Nations Climate Change Conference (COP26) takes place in Glasgow, Scotland. Read the scientists’ guide to the conference here.

And, in a victory for drug repurposing, a new study reports that the common antidepressant fluvoxamine is effective at preventing mild COVID-19 cases from becoming severe.

(Image Credit: Silvia Izquierdo/AP/Shutterstock)

Finally, a pilot study from the University of Minnesota Medical School has found that stimulating a specific brain region with small amounts of electrical energy can improve cognitive control abilities, showing promise for patients with depression and mental illness.

Kyla Germain

Kyla is a PhD candidate in the Department’s of Biochemistry (University of Toronto) and Cell Biology (The Hospital for Sick Children), where she studies the cellular basis of a pediatric brain disease. She has a continued interest in science communication for all audiences and has led the LSCDS writing team for three years.

Previous

LSCDS #ScienceNews and #Innovation
Next

Career Seminar Recap: Science Communication